1 1

FDA NDA 020103, ZOFRAN, SANDOZ, 12/31/1992

FDA NDA 020103, ZOFRAN, SANDOZ, 12/31/1992

$1,737.63 USD
$1,737.63 USD
Sale Sold out

Contents: Summary Basis of Approval for Zofran Tablets (NDA 020103) initial NDA approval, approved December 31, 1992, including the clinical pharmacology and biopharmaceutics reviews.

NDA: 020103
Company: SANDOZ
Drug Name: ZOFRAN
Active Ingredients: ONDANSETRON HYDROCHLORIDE
Strength: EQ 24MG BASE
Dosage Form/Route: TABLET;ORAL
Action Date: 12/31/1992
Marketing Status: Discontinued
Submission Classification: ORIG-1
Action Date: None

Pages 524
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome